Get the Stockscreener App
1.43
2.05%
-0.03
Humacyte Inc stock is traded at $1.43, with a volume of 2.54M.
It is down -2.05% in the last 24 hours and down -38.10% over the past month.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
See More
Previous Close:
$1.46
Open:
$1.45
24h Volume:
2.54M
Relative Volume:
0.60
Market Cap:
$226.47M
Revenue:
-
Net Income/Loss:
$-110.78M
P/E Ratio:
-1.3364
EPS:
-1.07
Net Cash Flow:
$-75.59M
1W Performance:
-7.74%
1M Performance:
-38.10%
6M Performance:
-54.60%
1Y Performance:
-73.91%
1-Day Range:
$1.38
$1.47
1-Week Range:
$1.38
$1.56
52-Week Range:
$1.15
$6.77
Humacyte Inc Stock (HUMA) Company Profile
Name
Humacyte Inc
Sector
Industry
Phone
919-313-9633
Address
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM
Compare HUMA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HUMA
Humacyte Inc
|
1.43 | 231.22M | 0 | -110.78M | -75.59M | -1.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Humacyte Inc Stock (HUMA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-27-25 | Initiated | Barclays | Overweight |
| May-14-25 | Resumed | H.C. Wainwright | Buy |
| Dec-20-24 | Reiterated | H.C. Wainwright | Buy |
| Dec-11-23 | Initiated | H.C. Wainwright | Buy |
| Aug-14-23 | Upgrade | Piper Sandler | Underweight → Neutral |
| Jun-22-23 | Initiated | Cantor Fitzgerald | Overweight |
| May-16-22 | Downgrade | Piper Sandler | Overweight → Underweight |
| Oct-29-21 | Initiated | Cowen | Outperform |
| Sep-24-21 | Initiated | Oppenheimer | Outperform |
| Sep-22-21 | Initiated | BTIG Research | Buy |
| Sep-16-21 | Initiated | Piper Sandler | Overweight |
View All
Humacyte Inc Stock (HUMA) Latest News
How do insiders feel about Humacyte Inc. Equity WarrantDollar Strength & AI Driven Stock Price Forecasts - 뉴스영
What data driven models say about Humacyte Inc. Equity Warrant’s futureJuly 2025 Gainers & Precise Buy Zone Identification - Newser
Humacyte, Senseonics jump as Barclays issues new Overweight ratings - MSN
Is now the right time to enter Humacyte Inc. Equity Warrant2025 Major Catalysts & Proven Capital Preservation Methods - خودرو بانک
Is Humacyte Inc. backed by strong institutional buyingJuly 2025 Pullbacks & Capital Efficiency Focused Ideas - خودرو بانک
What technical models suggest about Humacyte Inc.’s comeback2025 Trading Recap & Scalable Portfolio Growth Methods - Newser
Can Humacyte Inc. Equity Warrant disrupt its industryJuly 2025 Pullbacks & Low Risk Entry Point Guides - خودرو بانک
What’s the outlook for Humacyte Inc.’s sectorJuly 2025 Intraday Action & Precise Swing Trade Alerts - خودرو بانک
Can Humacyte Inc. Equity Warrant weather a recessionJuly 2025 Patterns & Advanced Swing Trade Entry Alerts - خودرو بانک
Can Humacyte Inc. deliver consistent dividendsJuly 2025 Review & Fast Entry Momentum Alerts - خودرو بانک
Is a relief rally coming for Humacyte Inc. holdersEarnings Performance Report & Precise Swing Trade Entry Alerts - Newser
Can swing trading help recover from Humacyte Inc. lossesQuarterly Risk Review & Daily Risk Controlled Trade Plans - Newser
How to monitor Humacyte Inc. Equity Warrant with trend dashboardsJuly 2025 Technicals & Fast Exit and Entry Trade Guides - Newser
Sector ETF performance correlation with Humacyte Inc. Equity Warrant2025 Trade Ideas & Real-Time Chart Breakout Alerts - Newser
Humacyte Inc. Equity Warrant stock momentum explainedJuly 2025 PostEarnings & Weekly High Return Opportunities - Newser
Visualizing Humacyte Inc. Equity Warrant stock with heatmapsJuly 2025 Spike Watch & Risk Controlled Daily Trade Plans - Newser
What’s the recovery path for long term holders of Humacyte Inc.2025 Buyback Activity & Fast Gain Swing Alerts - Newser
Humacyte Inc. stock chart pattern explained2025 Risk Factors & High Win Rate Trade Alerts - Newser
Can a trend reversal in Humacyte Inc. lead to recoveryQuarterly Trade Summary & Real-Time Sentiment Analysis - Newser
Applying Wyckoff theory to Humacyte Inc. stockWeekly Trade Analysis & High Accuracy Swing Entry Alerts - Newser
How to forecast Humacyte Inc. Equity Warrant trends using time seriesMarket Trend Summary & Reliable Entry Point Trade Alerts - Newser
Can trapped investors hope for a rebound in Humacyte Inc. Equity WarrantGDP Growth & Reliable Momentum Entry Alerts - Newser
Using AI based signals to follow Humacyte Inc. Equity WarrantRecession Risk & Daily Profit Maximizing Tips - Newser
Using Bollinger Bands to evaluate Humacyte Inc.2025 Price Momentum & Risk Managed Trade Strategies - Newser
Is Humacyte Inc. Equity Warrant in a long term uptrend2025 Investor Takeaways & Target Return Focused Stock Picks - خودرو بانک
Is Humacyte Inc. Equity Warrant forming a reversal patternQuarterly Trade Summary & Weekly Consistent Profit Watchlists - Newser
Using flow based indicators on Humacyte Inc. Equity WarrantMarket Performance Report & Fast Gain Stock Trading Tips - Newser
Applying big data sentiment scoring on Humacyte Inc.Quarterly Profit Report & Daily Market Momentum Tracking - Newser
Strategies to average down on Humacyte Inc. Equity WarrantJuly 2025 Big Picture & Real-Time Chart Breakout Alerts - Newser
HUMA Drops 3.31% on Weak Earnings, Insider Selling; Hits 2025 Low After 3-Day 7.59% Slide - AInvest
Aug Gainers: How do insiders feel about Humacyte Inc. Equity WarrantIndex Update & Weekly Setup with ROI Potential - خودرو بانک
Comparing Humacyte Inc. Equity Warrant in custom built stock radarsExit Point & High Accuracy Buy Signal Tips - Newser
Is Humacyte Inc. Equity Warrant Forming a Bottom Pattern2025 Risk Factors & Community Verified Watchlist Alerts - beatles.ru
Is Humacyte Inc. a turnaround storyMarket Rally & Low Risk Growth Stock Ideas - خودرو بانک
What indicators show strength in Humacyte Inc.Oil Prices & Fast Exit/Entry Strategy Plans - Newser
Can Humacyte Inc. navigate macro headwindsMarket Weekly Review & Growth Focused Stock Reports - خودرو بانک
Published on: 2025-09-03 06:28:25 - Newser
Custom watchlist performance reports with Humacyte Inc. Equity Warrant2025 Key Lessons & Daily Volume Surge Trade Alerts - Newser
How to manage a losing position in Humacyte Inc. Equity WarrantEarnings Summary Report & Community Trade Idea Sharing - Newser
Using Python tools to backtest Humacyte Inc. strategiesQuarterly Portfolio Review & Long-Term Safe Investment Plans - Newser
What data driven models say about Humacyte Inc.’s futureChart Signals & Long-Term Investment Growth Plans - Newser
Will Humacyte Inc. benefit from macro trends2025 Big Picture & Breakout Confirmation Trade Signals - Newser
Full technical analysis of Humacyte Inc. stockMarket Volume Summary & Short-Term Trading Opportunity Alerts - Newser
Published on: 2025-09-03 02:22:53 - Newser
What is Humacyte Inc.’s book value per shareTrade Performance Summary & Technical Entry and Exit Tips - خودرو بانک
Should you wait for a breakout in Humacyte Inc.Risk Management & Daily Entry Point Alerts - Newser
Real time social sentiment graph for Humacyte Inc. Equity WarrantJuly 2025 Trade Ideas & Long-Term Growth Portfolio Plans - Newser
Price momentum metrics for Humacyte Inc. explainedJuly 2025 Technicals & Low Risk Entry Point Guides - Newser
Humacyte Inc Stock (HUMA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Humacyte Inc Stock (HUMA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Dougan Brady W | Director |
Aug 18 '25 |
Sale |
1.83 |
549,360 |
1,005,329 |
1,691,685 |
| Dougan Brady W | Director |
Aug 20 '25 |
Sale |
1.58 |
591,685 |
934,862 |
0 |
| Niklason Laura E | President, CEO and Director |
Aug 19 '25 |
Sale |
1.63 |
1,100,000 |
1,793,000 |
591,685 |
| Niklason Laura E | President, CEO and Director |
Aug 18 '25 |
Sale |
1.83 |
549,360 |
1,005,329 |
1,691,685 |
| Niklason Laura E | President, CEO and Director |
Aug 20 '25 |
Sale |
1.58 |
591,685 |
934,862 |
0 |
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):